Molecular Imaging/ Nuclear Medicine


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Molecular Imaging/ Nuclear Medicine

  1. 1. Radiological Society of North America 95th Scientific Assembly and Annual Meeting November 29–December 4, 2009 McCormick Place, Chicago Molecular Imaging/ Nuclear Medicine SUBSPECIALTY CONTENT BROCHURE RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  2. 2. Subspecialty content brochures organize the components of the annual meeting by subjects that correspond to radiologic subspecialties. We hope this brochure, along with the Meeting Program, helps to enrich and ease your experience at RSNA 2009. RSNA Annual Meeting CME Information RSNA® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. RSNA designates this educational activity for a maximum of 90.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. indicates a course being offered as a self-assessment module (SAM). Sunday, November 29, 2009 10:45-12:15 Scientific Paper Sessions ISP: Molecular Imaging (Applications I) (Session SSA12) (S504CD) Nuclear Medicine (PET/CT in Oncology) (Session SSA18) (S505AB) 2:00-3:30 Refresher Courses Essentials of Molecular Imaging and Systems Diagnostics for Clinical Radiologists (Course RC117) (E352) PET Brain Imaging: Current and Emerging Applications—Emphasis on Dementia (Course RC111) (N228) Monday, November 30, 2009 8:30-10:00 Refresher Courses Improving Your PET Practice: Lessons Learned in Clinical Practice, with Emphasis on Case Studies, Image Correlation, and PET/CT(An Interactive Session) (Course RC211) (S103AB) Oncologic Imaging in the Era of Molecular Medicine (Course RC217) (S503AB) UpdateCourse in Diagnostic Radiology Physics: Imaging Technologies in Oncology—Imaging Lung Cancer (Course RC221) (S504AB) S RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  3. 3. 8:30-12:00 Multisession Course Breast/Nuclear Medicine/Molecular Imaging Series: Breast Imaging in the Era of Molecular Medicine (Course VM21) (Arie Crown Theater) 10:30-12:00 Scientific Paper Sessions ISP: Nuclear Medicine (PET/CT of Lymphoma and Other Neoplasms) (Session SSC14) (S505AB) Molecular Imaging (Multimodality) (Session SSC09) (S504CD) 1:30-5:45 Plenary Session Physics Symposium: Therapy Shielding and Physics and Applications of PET/CT (Session PS52) (S104A) 3:00-4:00 Scientific Paper Sessions ISP: Molecular Imaging (Ultrasound) (Session SSE13) (S504CD) Nuclear Medicine (Imaging the Brain: Structure and Function) (Session SSE19) (S505AB) Tuesday, December 1, 2009 8:30-10:00 Multisession Course Molecular Imaging: Here to Stay(Sponsored by the Associated Sciences Consortium) (Course AS31) (E350) Refresher Courses Neurologic Imaging in the Era of Molecular Medicine (Course RC317) (N229) PET for Assessing Treatment Response (Course RC311) (N226) Update Course in Diagnostic Radiology: Cardiac— Evaluation of Ischemia with CT, MR, and Nuclear Imaging (Course RC303) (N228) 10:30-12:00 Scientific Paper Sessions Molecular Imaging (Applications II) (Session SSG11) (S504CD) Nuclear Medicine (PET/CT of Gastrointestinal Malignancies) (Session SSG16) (S505AB) 1:30-2:45 Plenary Session Annual Oration in Diagnostic Radiology and Gold Medal Awards (Session PS60) (Arie Crown Theater) 3:00-4:00 Scientific Paper Sessions ISP: Molecular Imaging (Cell Tracking) (Session SSJ13) (S504CD) Nuclear Medicine (General Nuclear Medicine: Part 1) (Session SSJ19) (S505AB) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  4. 4. 4:30-6:00 Refresher Courses Advances and Updates in Gastrointestinal and Genitourinary Nuclear Medicine (Course RC411) (S503AB) Cardiovascular Imaging in the Era of Molecular Medicine (Course RC417) (E353A) Challenges in Diagnosis and Management of the Solid Renal Mass (Course RC407) (E351) Wednesday, December 2, 2009 8:30-10:00 Multisession Course Molecular Imaging: Overview and Basics (Course MI41) (S406B) Refresher Courses Imaging the Postoperative Urinary Tract (Course RC507) (S504AB) Radionuclide Imaging of Inflammation and Infection:A Multimodality Approach (Course RC511) (E351) 10:30-12:00 Multisession Course Molecular Imaging in Oncology (Course MI42) (S406B) Scientific Paper Session ISP: Nuclear Medicine (Clinical Utility of Quantitative Imaging) (Session SSK16) (S505AB) 1:30-2:45 Multisession Course Molecular Imaging in Cardiovascular Disease (Course MI43) (S406B) 3:00-4:00 Scientific Paper Session Nuclear Medicine (General: Part 2) (Session SSM18) (S505AB) 3:15-4:45 Multisession Course Molecular Imaging in Brain Disorders (Course MI44) (S406B) 4:30-6:00 Focus Session Is PET a Reliable Indicator of Tumor Viability in the Head and Neck? (Session SFN03) (S404AB) Thursday, December 3, 2009 8:30-10:00 Multisession Courses Case-based Review of Nuclear Medicine: PET/CT Workshop—Head and Neck Cancers (In Conjunction withSNM) (Course CC51) (E353B) Refresher Courses Interventional Radiology in the Era of Molecular Medicine (Course RC617) (E353A) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  5. 5. Minicourse: Innovations and Advances in Medical Imaging Technology—ACR Accreditation of SPECT and PET (Course RC623) (S504CD) Update Course in Diagnostic Radiology: Cardiac— New Developments in SPECT and PET of the Heart (Course RC603) (S103CD) 10:30-12:00 Multisession Courses Case-based Review of Nuclear Medicine: PET/CT Workshop—Cancers of the Thorax (In Conjunction withSNM) (Course CC52) (E353B) Essentials of Nuclear Medicine (Course ES52) (S406B) Scientific Paper Sessions ISP: Nuclear Medicine (Endocrine and Neuroendocrine Imaging) (Session SSQ15) (S505AB) Molecular Imaging (Applications III) (Session SSQ11) (S504CD) 1:30-3:00 Multisession Course Case-based Review of Nuclear Medicine: PET/CT Workshop—Cancers of the Abdomen and Pelvis (In Conjunction withSNM) (Course CC53) (E353B) 3:00-4:00 Focus Session SUVs in PET Imaging: A Blessing and a Curse (Session SFS08) (S404AB) 3:30-5:00 Multisession Course Case-based Review of Nuclear Medicine: PET/CT Workshop—Sarcoma/Melanoma/Lymphoma (In Conjunction withSNM) (Course CC54) (E353B) 4:30-6:00 Refresher Course Genitourinary Imaging in the Era of Molecular Medicine (Course RC717) (S404CD) Friday, December 4, 2009 8:30-10:00 Refresher Courses Advances in Cardiac Nuclear Imaging: SPECT/CT and PET/CT (Course RC811) (S503AB) Gastrointestinal Imaging in the Era of Molecular Medicine (Course RC817) (S404CD) 10:30-12:00 Scientific Paper Sessions Gastrointestinal (Oncology: MR, CT, and PET Imaging) (Session SST05) (E353C) Nuclear Medicine (PET/CT of Neckand Chest Malignancies) (Session SST12) (S505AB) Physics (PET and SPECT) (Session SST14) (S403B) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  6. 6. Education Exhibits CME is available when the author is present for discussion during the lunch period. Days are listed in parentheses. Space No. Title LL-ED0009 Nuclear Medicine Case of the Day Exhibit LL-MI2301 Functional Tumoral Imaging Made Easy LL-MI2302 Neuroendocrine Tumors Revisited: The Role of Multimodality Imaging with Somatostatin Receptor Scintigraphy (SRS) and GLUT Receptor Imaging with FDG PET/CT LL-MI2303 Stem Cell Tracking with MR Imaging and Optical Imaging LL-MI2304 Molecular Imaging Using Lipid-based Nanoprobes for MRI LL-MI2305 Nanotechnology's BigPromise for Radiology: A Byte- sized Conceptual Review of the Science of the Small LL-MI3010 Principle of Molecular Imaging Using Nano-Gold Labeled Molecules and Tuned k-edge Computed Tomography LL-MI3011-D A Radiologist’s Primer on Molecular and Functional Imaging of Cancer: From Neovascularization to the Nucleus (Monday) LL-MI3012-H How to Measure Neurotransmitters with MRS and PET: Focus on GABA, Glutamate, and Dopamine (Tuesday) LL-MS2528 CT, PET/CT, and MRI Findings of Tyrosine Kinase Receptor Inhibitor Cancer Therapies: Expected and Unexpected Radiographic Patterns of Response LL-NM2306 False Positive Activity on Postthyroidectomy I-131 Whole Body Scintigraphy: A Review and Presentation of Novel Techniques LL-NM2307 Pitfalls in the Interpretation of Interval Changes in Successive Whole Body Bone Scintigrams: Lessons Learned from a Prospective Clinical Study LL-NM2308 F18-FDG PET/CT Findings of Uncommon Hepatobiliary/Liver Tumors LL-NM2309 Illustrative Review of the Radionuclide Manifestations and Complications of Sickle Cell Anaemia LL-NM2310 New Role of Sentinel Node Mapping Using 3D SEPCT-CT Fusion Imaging in Oral Cavity Cancer LL-NM2311 Tc-99m MDP BoneScan Findings: Correlation with MRI and CT LL-NM2312 Nuclear Neuropsychiatric Imaging: What Radiology Residents Need to Know LL-NM2313-H07 Update on Diagnostic Accuracy of V/Q Scan for the Diagnosis of Pulmonary Embolism (Tuesday) LL-NM2314 Potential Role of Dedicated Multislice SPECT-CT in Oncology RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  7. 7. LL-NM2315 Role of Dedicated Multislice SPECT-CT Imaging in Orthopaedics LL-NM2316 One of These Things Is Not Like the Other: Utility of Pattern Recognition in the Detection of Unsuspected Additional Primary Malignancies on PET-CT LL-NM2317 PET-CT in the Evaluation and Management of Unique and Uncommon Pediatric Malignancies LL-NM2318 The Updated Imaging Diagnosis of Malignant Lymphoma Based on WHO Classification LL-NM2319 'New' Metastatic Disease Diagnosed on 18-FDG PET/CT: Should It Have Been Identified on Previous Staging Imaging? LL-NM2320-D07 PET/CT in the Evaluation of the Stomach, Duodenum, and Small Bowel (Monday) LL-NM2321 Clinical Value of FDG-PET in Pediatric Oncology LL-NM2322 Clinical Application of F-18 FLT PET for the Evaluation of Lung Diseases LL-NM2323 Extranodal Lymphoma: Spectrum of PET/CT Findings LL-NM2324 PET of Pediatric Bone DiseaseUsingF18 Sodium Fluoride (NaF) LL-NM2325 UnconventionalFluorodeoxyglucose (FDG) Avid Disease Entities and Unexpected Patterns of FDG Avidity Seen in Malignant Diseases Utilizing FDG PET-CT: A Pictorial Essay LL-NM2326-H06 Seizure Diagnosis Using Multimodality Imaging of MEG, MRI, PET, and SPECT (Tuesday) LL-NM2327 The Role of Diagnostic Contrast-enhanced PET/CT in Intensity-modulated Radiation Therapy Planning: Usefulness and Limitations with Emphasis on Head and Neck Malignancies LL-NM2328 Pancreatic Cancer: Evaluation with 18F-FDG PET/CT—A Pictorial Review LL-NM2329 The Standardized Uptake Value in FDG PET Imaging: Challenges in Acquisition and Application LL-NM2330 Assessment of Immediate Therapeutic Response to Radiofrequency Ablation and Surveillance of Recurrence in Neoplastic Lesions: Demonstration with FDG PET-CT LL-NM2331 The Role of FDG-PET in the Diagnosis, Staging, and Treatment Response in Patients with Posttransplant Lymphoproliferative Disorder LL-NM2332-L07 Management of Differentiated Thyroid Cancer: Emphasis on the Role of Imaging and Radioiodine Therapy (Wednesday) LL-NM2333 How Much 131-I Should We Use to Treat Grave’s Hyperthyroidism? As Well as: How to Handle Patient Work-up, Patient Dosing, and Follow-up LL-NM2334-R07 Radioiodine Therapy for Benign Thyroid Disease (Thursday) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  8. 8. LL-NM3101 FDG PET/CT Scan in Oral and Oropharyngeal Cancers: Role in Staging and Restaging, Pathological Patterns, Pearls and Pitfalls, Rare, and Frequent Normal Variants LL-NM3102 Benign, Ambiguous, and Malignant Musculoskeletal Lesions: F-18 FDG PET/CT Imaging LL-NM3103 E-NUCS: Online Evaluation and Skills Development in Nuclear Medicine with a Focus on Hybrid Modalities such as PET/CT and SPECT/CT LL-NM3104 Imaging Lymphoma Involvement of the Peripheral Nervous System LL-NM3105 Back Pain after Spinal Surgery:Can Bone SPECT- CT Pin the Cause? A Preliminary Experience LL-NM3106 Iodine SPECT-CT: Is There a Point? LL-NM3107-H Current SPECT/CT Hybrid Technologies: A Technical and Clinical Review (Tuesday) LL-NM3108-D Nuclear Medicine Assessment of Non-Target Organ Response to Oncology Therapy (Monday) LL-NM3109 Role of I-131 SPECT/CT in Addition toPlanar Imaging in the Assessment of Differentiated Thyroid Cancer Post I-131 Ablation LL-NM3110 Organs They Never Taught You about in Bone Scan School: Localization and Significance of Nonosseous Nonurologic Uptake Observed during Bone Scintigraphy Scientific Posters CME is available when the author is present for discussion during the lunch period. Days are listed in parentheses. Space No. Title LL-MI2001-B01 Development of 13C Chemical Shift MR Iimaging for the Depiction of Gliomas Enriched with 13C-Labeled Methionine at 4.7T (Sunday) LL-MI2002-B02 Diagnostic Role of 3T Diffusion-weighted Whole Body Magnetic Resonance in Staging Hodgkin's and Non-Hodgkin's Lymphoma: Comparison with F18- FDG PET-CT (Sunday) LL-MI2003-D01 Equivalent Cross Relaxation Rate Imaging for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer (Monday) LL-MI2004-D02 Longitudinal Cellular Imaging of B Cell Depletion Therapy in Vivo (Monday) LL-MI2005-H01 Microdosing Study for Evaluating Pharmacokinetics (PK) by Means of Planar Positron Imaging System (PPIS): A Comparison between Microdose and Therapeutic Dose PK of Antiepileptic Drug 11C- diphenyl hydantoin (DPH) in Rats (Tuesday) LL-MI2006-H02 Imaging of Neural Progenitor Cell Homing to Nonneural Tumors (Tuesday) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  9. 9. LL-MI2007-L01 Monitoring ER Stress in the Micro-Environments of Spontaneous Tumors as a Predictor for Tumor Growth (Wednesday) LL-MI2008-L02 In Vivo Bioluminescence Imaging: Monitoring of the Tumor Protective Protein Hypoxia Inducible Factor- 1α in Response to Conventional and Low Dose Metronomic Chemotherapy (Wednesday) LL-MI2009-R01 Multiparametric MR Imaging for Antiangiogenic Tumor Treatment Monitoring: A Preclinical Study (Thursday) LL-MI2010-R02 Cellular Imaging Using Equivalent Cross Relaxation Rate Technique in Rabbit VX-2 Tumor Model (Thursday) LL-NM2011-B01 Differential Diagnosis and Assessment of Prognosis in Malignant Pleural Mesothelioma with 18F-FDG- PET (Sunday) LL-NM2012-B02 Application of 18F-FDG PET/CT Imaging in Soft Tissue Metastasis (Sunday) LL-NM2013-B03 Nonpalpable Beast Cancer Lesion Excision: A Comparison between Radioguide Occult Lesion Locatization (ROLL) vs Wire Guide Lumpectomy (WGL) (Sunday) LL-NM2014-B04 Evaluation of Neuroinflammation in Experimental Autoimmune Encephalomyelitis Mice with Micro Positron Emission Tomography and Micro Magnetic Resonance Imaging (Sunday) LL-NM2015-B05 PET Manifestation in Different Pathology in Epilepsy (Sunday) LL-NM2016-B06 SPECT-CT Imaging in the Assessment of Non- specific Foot and Ankle Pain (Sunday) LL-NM2017-B07 Prospective Semiquantitative Analysis on FDG PET- CT Imaging Features before, 3, and 6 Months after RFA of Lung Tumors (Sunday) LL-NM2018-B08 F-18 FDG PET/CT Imaging of Myeloma (Sunday) LL-NM2019-D01 Is Heart Rate a Risk Factor for Coronary Disease? (Monday) LL-NM2020-D02 Comparison of Indine-123- metaionidobenzylguanidine Scintigram with Contrast-enhanced MR Imagingfor Detection of Myocardial Damage in Patients with Dilated Cardiomyopathy (Monday) LL-NM2021-D03 A Study to Obtain the Reliability of the SUV in PET/CT Systems (Monday) LL-NM2022-D04 Accuracy and Usefulness of 99mTc-Sestamibi SPECT/CT in the Localisation of Parathyroid Abnormalities: Surgical and Histological Correlation (Monday) LL-NM2023-D05 Ovarian and Endometrial18F-FDG Uptake during the Menstrual Cycle in Normal Premenopausal Patients: Evaluation by PET/CT (Monday) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  10. 10. LL-NM2024-D06 Comparison of FDG Uptake with Pathological Parameters in the Well-differentiated Thyroid Cancer (Monday) LL-NM2025-H01 Characterization of Damaged Myocardium in Acute Myocardial Infarction Using Gated Myocardial Perfusion Single-photon Emission Computed Tomography (SPECT) and Cardiac Magnetic Resonance Imaging (CMR) (Tuesday) LL-NM2026-H02 Thyroid Cancer in Toxic Thyroid Nodules: Case Report and Review of the Literature (Tuesday) LL-NM2027-H03 Can Calcification Predict131 Accumulation on Metastatic Lymph Nodes in Papillary Thyroid Carcinoma Patients Receiving I-131 Therapy? Comparison among CT, I -131 WBS, and F-18 FDG PET/CT (Tuesday) LL-NM2028-H04 Incidence of False Positive Chest Uptake on Indium- labeled Pentetreotide (OctreoScan) for Suspected Neuroendocrine Tumors (Tuesday) LL-NM2029-H05 Incidental Parotid Uptake on FDG PET/CT: Frequency and Relevance (Tuesday) LL-NM2030-L01 Association of Vascular FDG Uptake with Aorta and Carotid Artery in Patients with Aortic Aneurysm (Wednesday) LL-NM2031-L02 Can 99mTc-sestamibi Thyroid Scintigraphy Make the Difference in the Differential Diagnosis of Amiodarone-induced Thyrotoxicosis? (Wednesday) LL-NM2032-L03 Comparative Benefit of CT Scan and Total Body FDG-PET in the Follow-up of Patients with Differentiated Thyroid Cancer with Negative Post- therapy 131I-WBS and Serum Tg Levels Detectable (Persistence of Disease) (Wednesday) LL-NM2033-L04 Comparison of I-123 IMP SPECT, F-18 FDG PET/CT, and F-18 Dopa PET/CT in Detection of Uveal Malignant Melanoma (Wednesday) LL-NM2034-L05 Usefulness of 18F-Fluoride PET/CT in Bone Metastasis of Prostate Cancer (Wednesday) LL-NM2035-L06 Clinical FDG PET CT in the Investigation of Suspected Inflammatory and Infective Conditions (Wednesday) LL-NM2036-R01 A Technique for Reducing the Influence of Scattered Rays from Surrounding Organs to the Heart during Gated Cardiac Blood Pool Scan (Thursday) LL-NM2037-R02 F-18 FDG PET/CT in Pancreatic Tumors: Is the Differential Diagnosis between Pancreatic Cancer and Mass-forming Pancreatitis Possible? (Thursday) LL-NM2038-R03 Correlation of ENT1, TK1, dNT, TMPK, and PCNA Expressions with F-18 FLT Uptake in Colorectal Cancer (Thursday) LL-NM2039-R04 Lymphoscintigraphy as a Useful Method in the Study of Young Patients with Oedemas and Congenital Pathology Associated Malformations (Thursday) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  11. 11. LL-NM2040-R05 Accuracy of FDG-PET/CT in the Mediastinic Staging of Patients with Non Small Cell Lung Cancer (NSCLC) (Thursday) LL-NM2041-R06 [18F]FDG-PET/CT Diagnosis of Recurrent Intraabdominal Cancer in Asymptomatic Patients with Elevated Tumor Marker Serum Levels and Negative Findings on Conventional Imaging Tests (Thursday) RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09
  12. 12. RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09